Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types
Authors
Keywords
cancer, clinical trials, patient-reported outcomes, regulatory
Journal
VALUE IN HEALTH
Volume 24, Issue 9, Pages 1302-1307
Publisher
Elsevier BV
Online
2021-06-25
DOI
10.1016/j.jval.2021.04.1279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reporting of HRQoL results from the PALOMA-2 trial: Relevant data are still missing
- (2018) T Kaiser et al. ANNALS OF ONCOLOGY
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
- (2018) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop
- (2018) Paul G. Kluetz et al. VALUE IN HEALTH
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
- (2017) Ethan Basch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity
- (2017) Alessandro Inno et al. TUMORI
- Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity
- (2017) Alessandro Inno et al. TUMORI JOURNAL
- Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right
- (2016) Chris Schilling et al. VALUE IN HEALTH
- Symptom Burden and Quality of Life in Survivorship
- (2015) Horng-Shiuann Wu et al. CANCER NURSING
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
- (2015) Massimo Di Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials
- (2015) Gita Thanarajasingam et al. JNCI-Journal of the National Cancer Institute
- The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials
- (2015) Gita Thanarajasingam et al. JNCI-Journal of the National Cancer Institute
- Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours
- (2013) G Yadegarfar et al. BRITISH JOURNAL OF CANCER
- Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer
- (2012) David Cella et al. QUALITY OF LIFE RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started